BCBS Michigan scores $147M in savings through biosimilars
(By: Elizabeth Casolo for Becker’s Hospital Review ) BCBS Michigan saved $67 million and $80 million in 2024 and 2025,
Read More
Biosimilars drugs
FDA’s Plan To Boost Biosimilar Drugs Could Stall at the Patent Office
(By Arthur Allen for KFF Health News) While the FDA is streamlining regulation of copycat versions of the expensive drugs
Read MoreFDA Moves to Accelerate Biosimilar Development and Lower Drug Costs
(Source - www.hhs.gov) WASHINGTON— OCTOBER 29, 2025 — The U.S. Food and Drug Administration (FDA) today announced significant action to
Read MoreShould CMS monitor biosimilar coverage on formularies?
The U.S. Department of Health and Human Services Office of Inspector General (OIG) released a study that found many Medicare
Read MoreOptum joins CVS, Cigna in dropping Humira
(By Rylee Wilson for Becker’s Hospital Review ) Optum Rx will join the other major pharmacy benefit managers and exclude
Read MoreWhat 5 recent studies found about Medicare Advantage
(By Rylee Wilson for Becker’s Hospital Review ) Recent research on Medicare Advantage has tracked competition in local markets and
Read MoreCareFirst sues J&J over alleged anticompetitive biosimilar tactics
(By Andrew Cass for Becker’s Hospital Review ) CareFirst BlueCross BlueShield has filed a proposed class-action lawsuit accusing Johnson &
Read MoreSave Billions or Stick With Humira? Drug Brokers Steer Americans to the Costly Choice
(By Arthur Allen for KFF Health News) Tennessee last year spent $48 million on a single drug, Humira — about
Read MoreAbbVie’s blockbuster drug Humira finally loses its 20-year, $200 billion monopoly
(Leslie Walker and Dan Gorenstein for NPR) After 20 years and $200 billion in revenue, Humira — an injectable treatment
Read More